Sales and Marketing

Showing 15 posts of 11472 posts found.

GSK’s RSV vaccine ready to launch

March 9, 2023 Sales and Marketing

GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …

Funding to increase access to early phase clinical trials given to Yale Cancer Center

March 7, 2023 Sales and Marketing

Yale Cancer Center has announced it has received collaborative funding aiming to support and increase access to early phase clinical …

Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment

March 3, 2023 Sales and Marketing

US-based pharmaceutical company Eli Lilly has signed a small licensing deal with Belgian start-up Confo Therapeutics to allow them access …

Moderna to pay $400m to US government over new COVID-19 vaccine license

February 28, 2023 Sales and Marketing

Moderna, a leader in the development of COVID-19 vaccines, announced that it has paid the National Institute of Allergy and …

Stryker’s Q Guidance System received FDA clearance for cranial applications

February 20, 2023 Sales and Marketing

Stryker, a medical technology company, has announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from …

Sorrento Therapeutics’ subsidiary Scilex Holding Company acquires rights to acute migraine treatment

February 13, 2023 Sales and Marketing

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, has announced that it has acquired the rights to ELYXYBTM (celecoxib oral …

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

February 10, 2023 Sales and Marketing

AbbVie Inc has announced that it expects to see a 37% decline in sales of its flagship rheumatoid arthritis drug …

Garuda Therapeutics closes series B funding with $62m

February 9, 2023 Sales and Marketing

Cambridge-based Garuda Therapeutics announced it closed a $62m series B funding round to support its off-the-shelf, self-renewing blood stem cell …

Strong sales of Basilea’s Cresemba triggers second sales milestone payment from Pfizer

February 7, 2023 Sales and Marketing

Swiss commercial-stage biopharmaceutical company Basilea Pharmaceutica Ltd has announced that continued high sales of its drug Cresemba (isavuconazole) in China …

Tadashi Maruno

February 2, 2023 Sales and Marketing

  Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and PresidentHamamatsu Photonics, a leading provider of cutting-edge photonics technology, …
illumina_joydeep_goswami

Joydeep Goswami

February 2, 2023 Sales and Marketing

Illumina Appoints Joydeep Goswami Chief Financial Officer

COVID-19 treatments drive Pfizer’s annual earnings up to $100bn

February 1, 2023 Sales and Marketing

Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine …

Novo Nordisk accused of violating FDA’s Fair Balance advertising policy

January 24, 2023 Sales and Marketing

Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo …

AstraZeneca set to buy CinCor for $1.8bn

January 9, 2023 Sales and Marketing

AstraZeneca has announced that it is set to acquire the clinical-stage biopharmaceutical company CinCor in a deal worth up to …

Moderna agrees first acquisition for $85m

January 6, 2023 Sales and Marketing

After a pivotal few years, Moderna has agreed its first acquisition, worth $85m, which will allow the company access to …

Latest content